Does Impairment Affect EBITDA? 2026 Guide With Examples

Usually, an impairment loss does not reduce EBITDA when the company’s EBITDA measure excludes impairment as a non-cash or separately adjusted item. However, EBITDA is not a line item defined by Ind AS or IFRS, so the exact treatment depends on how EBITDA is calculated and presented. Impairment generally reduces reported operating profit/EBIT and profit before tax, while also reducing the carrying amount of the impaired asset.

For CFOs, investors and valuation professionals, the more important question is not simply whether impairment is added back to EBITDA. It is why the impairment occurred and whether it signals a deterioration in the future cash-generating ability of the business or asset.

Key Takeaways

• Ind AS 36 and IAS 36 require an impairment loss when an asset’s or cash-generating unit’s carrying amount exceeds its recoverable amount.
• Recoverable amount is the higher of Value in Use (VIU) and Fair Value Less Costs of Disposal (FVLCD).
• An impairment charge is generally a non-cash expense when recognised, but it reduces the carrying amount of the relevant asset or CGU.
• Impairment generally reduces reported EBIT/operating profit and profit before tax, while its effect on EBITDA depends on the company’s definition and presentation of EBITDA.
• A ₹10 crore impairment may be added back when calculating an Adjusted EBITDA measure if it has reduced the starting earnings measure and is genuinely non-recurring—but analysts should not automatically ignore the economic reasons behind the impairment.

An impairment loss arises when the carrying amount of an asset or cash-generating unit (CGU) exceeds its recoverable amount.

In simple terms, an asset may be recorded in a company’s books at a value that can no longer be supported by its expected economic benefits or disposal value. When this happens, the carrying amount may need to be written down.

Under Ind AS 36 – Impairment of Assets, recoverable amount is the higher of:

1. Fair Value Less Costs of Disposal (FVLCD), and
2. Value in Use (VIU).

If the recoverable amount is below the carrying amount, an impairment loss is generally recognised for the difference, subject to the requirements of the applicable accounting standard.

Simple impairment example

Assume a manufacturing company has a cash-generating asset with:

• Carrying amount: ₹10 crore
• Value in Use: ₹7 crore
• Fair Value Less Costs of Disposal: ₹7.5 crore

The recoverable amount is ₹7.5 crore because it is the higher of VIU and FVLCD.

Impairment loss = ₹10 crore − ₹7.5 crore = ₹2.5 crore

The carrying amount would therefore be reduced by ₹2.5 crore, subject to the applicable accounting treatment.

Impairment does not necessarily reduce EBITDA, but the answer depends on how EBITDA is defined.

EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortisation. However, impairment is not explicitly one of the four items named in EBITDA, and EBITDA itself is not a standardised Ind AS or IFRS accounting measure.

This creates an important distinction.

A company may present an EBITDA measure that already excludes impairment, particularly where impairment is separately disclosed. Another company or analyst may start with an earnings figure that includes the impairment charge and then add it back when calculating Adjusted EBITDA.

Therefore, saying that impairment “never affects EBITDA” is too broad.

The correct analysis is:

Check the starting earnings measure → check where the impairment has been recognised → check the company’s EBITDA definition → determine whether an adjustment is appropriate.

For investors and valuers, an impairment charge may be excluded from a normalised earnings metric when it is non-cash and non-recurring. But the underlying cause of impairment should still be considered when forecasting future cash flows and assessing valuation risk.

The financial impact differs depending on the metric being analysed.

The key distinction

An impairment charge can be non-cash today but economically significant for tomorrow.

For example, impairment caused by temporary accounting circumstances may have limited implications for recurring operating earnings. But impairment caused by structural demand decline, technological obsolescence, loss of a major customer or deteriorating margins could indicate weaker future cash flows.

That distinction matters significantly in business valuation.

Consider a simplified company with the following figures before impairment:

If the company’s defined EBITDA measure excludes the separately recognised ₹10 crore impairment charge, EBITDA remains ₹40 crore, while EBIT falls from ₹32 crore to ₹22 crore.

If, however, an analyst starts with an earnings measure that includes the impairment charge, the analyst must reconcile the calculation carefully before describing the resulting number as EBITDA or Adjusted EBITDA.

The ₹10 crore should not simply be added again to an EBITDA number that already excluded the impairment.

This distinction prevents double-counting and makes EBITDA comparisons more reliable.

An impairment loss is generally recognised immediately in profit or loss, unless another accounting treatment applies—for example, where the relevant asset is carried at a revalued amount and the impairment is treated in accordance with the applicable standard.

The exact presentation can differ depending on:

• the type of asset,
• materiality,
• applicable accounting policies,
• financial statement presentation, and
• disclosure requirements.

For analytical purposes, CFOs and investors should review both the primary financial statements and notes rather than assuming that every impairment appears under the same line item.

The impairment also reduces the carrying amount of the relevant asset or CGU on the balance sheet.

independent valuation for impairment testing

Yes, recognising an impairment loss is generally a non-cash accounting event at the time it is recorded. The accounting entry reduces the carrying amount of an asset without requiring an equivalent cash payment at that moment.

This is one reason impairment may be adjusted when analysts calculate normalised or adjusted earnings.

However, “non-cash” does not mean “irrelevant.”

An impairment may indicate:

• declining future cash flows,
• loss of customers or contracts,
• technological obsolescence,
• lower asset utilisation,
• weaker market conditions,
• adverse regulatory changes,
• reduced profitability,
• unsuccessful acquisitions, or
• deterioration in the economics of a CGU.

For valuation purposes, the reason for impairment is often more important than the accounting entry itself.

Under Ind AS 36, entities assess at the end of each reporting period whether there is an indication that an asset may be impaired. If such an indication exists, the entity estimates the asset’s recoverable amount.

Certain assets are subject to specific annual testing requirements under the standard, including goodwill acquired in a business combination and certain intangible assets.

Potential external and internal impairment indicators can include:

External indicators

• Significant decline in an asset’s market value
• Adverse economic or industry changes
• Technological disruption
• Regulatory changes
• Changes in interest rates or market rates of return
• Deteriorating market conditions

Internal indicators

• Physical damage
• Technological or commercial obsolescence
• Asset underutilisation
• Plans to discontinue or restructure operations
• Performance materially below expectations
• Evidence that an asset’s economic performance is deteriorating

Management should evaluate the facts and circumstances relevant to the asset or CGU rather than treating impairment testing as a mechanical year-end exercise.

The basic impairment framework can be understood in four steps.

Step 1: Determine the carrying amount

Identify the amount at which the relevant asset or CGU is currently recognised in the financial statements.

Step 2: Determine Value in Use

Value in Use (VIU) represents the present value of future cash flows expected to be derived from the asset or CGU, calculated in accordance with the requirements of Ind AS 36.

The analysis may require assumptions relating to:

• forecast revenue,
• operating margins,
• capital expenditure,
• working capital,
• long-term growth,
• useful economic life, and
• an appropriate discount rate.

Step 3: Determine Fair Value Less Costs of Disposal

FVLCD considers the fair value of the asset or CGU after deducting costs associated with disposal.

Depending on the asset and available market evidence, this may involve:

• market transactions,
• comparable-company evidence,
• asset-level market evidence,
• valuation techniques, or
• other relevant observable and unobservable inputs.

Step 4: Compare recoverable amount with carrying amount

Recoverable amount is the higher of VIU and FVLCD.

If:

Carrying Amount > Recoverable Amount

an impairment loss exists for the excess, subject to the applicable accounting requirements.

Example

Carrying amount of CGU: ₹150 crore

Value in Use: ₹120 crore

Fair Value Less Costs of Disposal: ₹130 crore

Recoverable amount: ₹130 crore

Potential impairment loss:

₹150 crore − ₹130 crore = ₹20 crore

The calculation itself appears simple. In practice, determining VIU and FVLCD can require substantial valuation judgement.

A cash-generating unit is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

CGU identification is particularly important where an individual asset does not generate independent cash flows.

For example, a single machine within a production line may not produce identifiable cash flows independently. In such circumstances, impairment testing may need to occur at the appropriate CGU level rather than treating the machine in isolation.

Incorrect CGU identification can materially affect:

• forecast cash flows,
• allocation of goodwill,
• recoverable amount,
• impairment conclusions, and
• financial statement disclosures.

Goodwill impairment is generally a non-cash write-down arising when the recoverable amount of the CGU or group of CGUs to which goodwill has been allocated does not support its carrying amount.

As with other impairment charges, the impact on a company’s reported EBITDA depends on the definition and reconciliation of the EBITDA measure being used.

For investors, goodwill impairment deserves additional attention because it can signal that assumptions supporting an earlier acquisition have weakened.

Possible causes include:

• acquisition performance below expectations,
• loss of key customers,
• reduced margins,
• higher discount rates,
• slower industry growth,
• competitive disruption, or
• changes in long-term forecasts.

Therefore, adding goodwill impairment back to adjusted earnings does not mean investors should ignore what caused it.

Impairment and depreciation both reduce asset-related accounting values, but they arise for different reasons.

A company may therefore report stable EBITDA while experiencing significant impairment. That does not necessarily mean its economic condition is unchanged.

Under Ind AS 36, impairment losses for certain assets may be reversed when there has been a change in the estimates used to determine recoverable amount, subject to the standard’s requirements and limits.

Goodwill is different: an impairment loss recognised for goodwill is not subsequently reversed.

This distinction matters when analysing historical earnings because an impairment charge and a later reversal can both affect reported accounting performance without necessarily representing equivalent changes in operating cash flow.

Analysts should therefore understand the underlying valuation assumptions rather than mechanically adding or subtracting impairment-related items.

An impairment accounting entry does not mechanically reduce enterprise value by the exact amount of the impairment charge.

Enterprise value is driven by the value attributed to the operating business and its expected economic performance. However, an impairment can provide important information about assumptions that influence valuation.

For example, impairment may signal:

• lower expected revenue,
• declining margins,
• reduced growth expectations,
• higher business risk,
• lower asset utilisation,
• increased discount rates, or
• reduced terminal value.

These factors may also reduce the value produced by a Discounted Cash Flow (DCF) analysis.

Impairment and EV/EBITDA

Suppose a company trades at an enterprise value of ₹800 crore and sustainable EBITDA of ₹100 crore.

Its EV/EBITDA multiple is:

₹800 crore ÷ ₹100 crore = 8.0x

If an impairment is excluded from EBITDA but the impairment reveals a structural deterioration in future cash flows, investors may reduce the enterprise value they are willing to assign to the business.

For example:

Enterprise value falls to ₹650 crore.

Sustainable EBITDA remains ₹100 crore.

EV/EBITDA = 6.5x

The accounting impairment did not mathematically change EBITDA, but the information behind the impairment contributed to a reassessment of business value.

Not automatically.

An impairment charge may be considered for adjustment when analysing normalised earnings because it is often non-cash and may be non-recurring. But an analyst should first determine whether the charge has already been excluded from the EBITDA measure being used.

The analyst should also ask:

1. Has impairment already been excluded from reported EBITDA?
2. Is the impairment genuinely non-recurring?
3. What caused the impairment?
4. Does the cause affect future operating performance?
5. Are forecast cash flows consistent with the impairment conclusion?
6. Will future depreciation or amortisation change because of the write-down?
7. Is the adjusted EBITDA measure being used consistently across periods and comparable companies?

An adjustment that improves EBITDA presentation without addressing deteriorating economics can result in an overstated valuation.

How Can Impairment Affect Future Depreciation and Earnings?

Once an asset’s carrying amount is reduced following impairment, future depreciation or amortisation may be based on the revised carrying amount over the remaining useful life, subject to the applicable accounting requirements.

This means impairment can affect financial statements beyond the period in which the initial loss is recognised.

For CFOs and valuation teams, it is therefore important to model:

• the immediate impairment charge,
• revised carrying values,
• subsequent depreciation/amortisation,
• deferred tax consequences where relevant,
• future earnings, and
• valuation assumptions.

Looking only at current-period EBITDA can miss these longer-term effects.

Different stakeholders examine impairment for different reasons.

For CFOs and finance teams

The priority is accurate financial reporting, defensible forecasts, appropriate CGU identification and documentation of valuation assumptions.

For auditors

The focus may include the reasonableness of management assumptions, cash-flow forecasts, discount rates, growth assumptions, valuation methodology and supporting evidence.

For investors

Impairment can reveal information about asset quality, acquisition performance and the credibility of previous growth assumptions.

For lenders

A significant impairment may be relevant to asset coverage, covenant analysis, credit risk and the company’s future cash-generating capacity.

For transaction teams

Historical impairment may require careful normalisation when analysing maintainable EBITDA, but its underlying causes remain relevant to due diligence and valuation.

Independent valuation support can be particularly useful where determining recoverable amount requires significant judgement or complex valuation inputs.

Companies may consider specialist support when:

• goodwill from an acquisition is material,
• a business or CGU is underperforming,
• forecasts have materially declined,
• a plant is operating below capacity,
• technology has made existing assets obsolete,
• market conditions have deteriorated,
• a significant customer or contract has been lost,
• the business has undergone restructuring,
• discount rates have materially changed,
• an asset has suffered physical or economic deterioration, or
• management or auditors require robust support for VIU or FVLCD assumptions.

The purpose of an independent valuation is not simply to calculate a number. A robust impairment analysis should establish a clear connection between financial forecasts, market evidence, valuation assumptions and the recoverable amount conclusion.

RNC Valuecon LLP provides independent valuation support for impairment testing, including Value in Use, Fair Value Less Costs of Disposal, CGU assessment, goodwill and intangible asset valuation, and recoverable amount analysis.

Our valuation professionals work with CFOs, finance teams, companies and other stakeholders where independent valuation analysis is required for financial reporting, audit support and strategic decision-making.

Discuss Your Impairment Valuation Requirement

The exact requirements depend on the asset, CGU and valuation approach, but an impairment assessment may require:

• Historical financial statements
• Management forecasts
• Budgets and business plans
• Fixed asset information
• Details of CGUs
• Acquisition documents
• Goodwill allocation
• Revenue and margin assumptions
• Capital expenditure forecasts
• Working-capital assumptions
• Industry and market data
• Discount-rate inputs
• Previous impairment assessments
• Management’s strategic outlook

Early preparation of these inputs can make the impairment-testing process more efficient and reduce last-minute issues during financial reporting or audit review.

Before starting an impairment assessment, finance teams should consider five questions.

1. Have circumstances changed since the last reporting period?

Review internal performance and external economic or market developments.

2. Are forecasts still supportable?

Compare previous forecasts with actual performance. Persistent forecast misses may require reassessment of future assumptions.

3. Are the CGUs still appropriate?

Changes in business structure, reporting or operations may affect CGU identification.

4. Are discount and growth assumptions current?

Macroeconomic conditions, risk-free rates, business risk and long-term growth expectations can materially influence recoverable amount.

5. Is there sufficient supporting documentation?

Major assumptions should be supported by internal evidence, market data and appropriate valuation analysis.

1. Is impairment included in EBITDA?

Impairment may be excluded from adjusted EBITDA when it is treated as a non-cash or separately adjusted expense. However, EBITDA is not a standardised measure under Ind AS or IFRS, so the treatment depends on how the company defines and calculates EBITDA.

2. Does impairment affect EBITDA?

The impact of impairment on EBITDA depends on the EBITDA definition being used. An impairment charge generally reduces accounting profit and EBIT when recognised in profit or loss, while many adjusted EBITDA calculations exclude impairment as a non-cash or separately identified item.

3. Does impairment affect EBIT?

Yes, an impairment loss recognised in profit or loss generally reduces EBIT or operating profit. Unlike conventional EBITDA, EBIT is calculated after depreciation and amortisation and can reflect impairment charges depending on financial statement presentation.

4. Is impairment a non-cash expense?

Yes. Recognising an impairment loss generally does not result in an immediate cash outflow. However, the reasons behind the impairment—such as declining performance, lower demand or asset obsolescence—may indicate weaker future cash flows.

5. Does goodwill impairment affect EBITDA?

Goodwill impairment is a non-cash accounting write-down. Whether it affects reported EBITDA depends on the company’s EBITDA definition. It is often excluded from adjusted EBITDA, but the underlying reasons for goodwill impairment may still be important when assessing future performance and valuation.

6. What is recoverable amount under Ind AS 36?

Under Ind AS 36, recoverable amount is the higher of an asset’s or cash-generating unit’s Value in Use and Fair Value Less Costs of Disposal. An impairment may arise when the carrying amount exceeds the recoverable amount.

7. How is an impairment loss calculated?

An impairment loss is generally determined by comparing an asset’s or cash-generating unit’s carrying amount with its recoverable amount. If carrying amount exceeds recoverable amount, the difference represents the impairment loss, subject to the requirements of the applicable accounting standard.

8. What is the difference between impairment and depreciation?

Depreciation systematically allocates the depreciable amount of an asset over its useful life. Impairment addresses situations where an asset’s carrying amount exceeds the amount recoverable under the applicable impairment requirements.

9. Can an impairment loss be reversed?

Under Ind AS 36, impairment losses for certain assets may be reversed when specified conditions are satisfied. However, an impairment loss recognised for goodwill cannot subsequently be reversed.

10. How does impairment affect business valuation?

An impairment charge does not automatically reduce enterprise value by the same amount. However, the factors causing impairment—such as lower expected cash flows, reduced growth or higher risk—can affect DCF assumptions, valuation multiples and overall business value.

The question “Does impairment affect EBITDA?” has a more nuanced answer than a simple yes or no.

An impairment charge is generally non-cash, and many EBITDA or adjusted EBITDA presentations exclude it. But because EBITDA is not a standardised Ind AS or IFRS measure, its treatment must be verified from the actual calculation.

More importantly, impairment can reduce EBIT and accounting profit, lower asset carrying values and signal deterioration in future economic performance.

For CFOs, investors and valuation professionals, the correct approach is therefore to look beyond the add-back.

Understand why the impairment occurred, determine its effect on sustainable cash flows, and ensure that the assumptions used for impairment testing and business valuation remain internally consistent.

Need an Independent Impairment Valuation?

RNC Valuecon LLP supports businesses with impairment testing and recoverable amount assessments under applicable financial reporting requirements.